Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Treatment for leiomyosarcoma and leiomyoma in children with HIV infection.

Authors
  • Yin, Xiangli
  • Wu, Taixiang
  • Yan, Yuping
  • Zhang, Hongying
  • Bu, Hong
Type
Published Article
Journal
The Cochrane database of systematic reviews
Publication Date
Jan 01, 2010
Issue
5
Identifiers
DOI: 10.1002/14651858.CD007665.pub2
PMID: 20464756
Source
Medline
License
Unknown

Abstract

In future, high-quality RCTs are urgently needed before any final conclusion can be drawn. Rigorously designed, multicenter, randomised, double-blind controlled trials are required to evaluate these interventions as a way of improving the survival and decreasing mortality in that population. Policy makers and researchers should prioritise funding for these trials to increase the quantity and quality of such studies and provide strong evidence for the effectiveness of therapies for AIDS-associated SMTs. Meanwhile, safety and adverse events should be critically assessed by standardized monitoring or an effective self-report system, and attention should be paid to long-term adverse effects in children with HIV infection.

Report this publication

Statistics

Seen <100 times